Compliance Rate

Compliance Rate 75.0%
Compliant submissions 3
Incompliant submissions 1
Total trials 4

My Organizations' Clinical Trials

Showing 325 of 876 entries
View as:

Indiana Palliative Excellence in Alzheimer's Care Efforts

Phase: N/A Priority: Normal
NCT ID: NCT03773757 Org: User:
Start: 03/14/19 End: 01/07/23 Due: 01/07/24

Cartilage Remodeling Using Low-Temperature Radiofrequency for Nasal Airway Reconstruction

Phase: N/A Priority: Normal
NCT ID: NCT07032675 Org: User:
Start: 08/01/25 End: 06/30/27 Due: 06/30/28

Overground Virtual Reality (VR) Gait Rehabilitation for Traumatic Brain Injury (TBI)

Phase: N/A Priority: Normal
NCT ID: NCT07038889 Org: User:
Start: 06/30/25 End: 06/30/27 Due: 06/30/28

POST Facilitation for Community Dwelling Older Adults (POST-RCT)

Phase: N/A Priority: Normal
NCT ID: NCT04070183 Org: User:
Start: 05/11/20 End: 08/31/25 Due: 08/31/26

Effect of the HCC Liver-Link Intervention

Phase: N/A Priority: Normal
NCT ID: NCT06728293 Org: User:
Start: 06/10/25 End: 01/31/26 Due: 01/31/27

Using Computers to Assist in the Diagnosis and Treatment of Attention-deficit/Hyperactivity Disorder (ADHD)

Phase: N/A Priority: Normal
NCT ID: NCT01351064 Org: User:
Start: 07/31/10 End: 07/31/12 Due: 07/31/13

Addressing Place and People Micro Environments in Weight Loss Disparities

Phase: N/A Priority: Normal
NCT ID: NCT03083964 Org: User:
Start: 01/18/17 End: 12/11/21 Due: 12/11/22

Syrenity App for Depression

Phase: N/A Priority: Normal
NCT ID: NCT06408025 Org: User:
Start: 05/15/24 End: 05/01/25 Due: 05/01/26

iMETX (Individualized Metabolic RX): a Pilot Study

Phase: N/A Priority: Normal
NCT ID: NCT03158519 Org: User:
Start: 05/15/17 End: 04/01/19 Due: 04/01/20

Mechanisms of Active Music Engagement to Improve Health Outcomes of Children With Cancer and Parents

Phase: N/A Priority: Normal
NCT ID: NCT03085927 Org: User:
Start: 09/26/16 End: 04/06/20 Due: 04/06/21

Cervical Myelopathy in Hip Fracture Patients

Phase: N/A Priority: Normal
NCT ID: NCT06893406 Org: User:
Start: 05/01/25 End: 03/20/26 Due: 03/20/27

Telephone Acceptance and Commitment Therapy Intervention for Caregivers of Adults With Dementia

Phase: N/A Priority: Normal
NCT ID: NCT04338750 Org: User:
Start: 03/24/20 End: 04/09/21 Due: 04/09/22

Use of Remimazolam and Fentanyl for Procedural Sedation in Patients Undergoing Dental Extraction

Phase: N/A Priority: Normal
NCT ID: NCT06793358 Org: User:
Start: 07/31/25 End: 03/30/26 Due: 03/30/27

Intraperitoneal Bupivacaine for Pelvic Organ Prolapse

Phase: N/A Priority: Normal
NCT ID: NCT06120530 Org: User:
Start: 08/16/23 End: 03/15/24 Due: 03/15/25

Program ACTIVE II: Behavioral Depression Treatment for Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT03371940 Org: User:
Start: 01/01/12 End: 07/31/17 Due: 07/31/18

Novel Approaches for Minimizing Drug-Induced QT Interval Lengthening

Phase: N/A Priority: Normal
NCT ID: NCT04675788 Org: User:
Start: 09/02/21 End: 04/16/25 Due: 04/16/26

Pulmonary Compliance Changes During Manipulation of Early Onset Scoliosis and Cast Application

Phase: N/A Priority: Normal
NCT ID: NCT02558985 Org: User:
Start: 09/30/15 End: 06/30/18 Due: 06/30/19

Comparison of Tissue Oxygenation Measurement Using Multimodal Devices

Phase: N/A Priority: Normal
NCT ID: NCT05784103 Org: User:
Start: 03/09/22 End: 07/07/22 Due: 07/07/23

Testing a Novel Community-based Occupational Therapy Model

Phase: N/A Priority: Normal
NCT ID: NCT03855761 Org: User:
Start: 02/18/19 End: 12/01/19 Due: 12/01/20

Comparison of Subcutaneous INFIX and EXFIX for Anterior Pelvic Ring Fractures Requiring Stabilization

Phase: N/A Priority: Normal
NCT ID: NCT02403154 Org: User:
Start: 04/30/14 End: 06/30/16 Due: 06/30/17

DFMO in Children With Type 1 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT02384889 Org: User:
Start: 04/30/15 End: 01/06/20 Due: 01/06/21

Post-resection Treatment of Large Colon Polyps

Phase: N/A Priority: Normal
NCT ID: NCT03654209 Org: User:
Start: 10/16/18 End: 12/14/22 Due: 12/14/23

The Indiana Myeloma Registry

Phase: N/A Priority: Normal
NCT ID: NCT03616483 Org: User:
Start: 06/18/18 End: 06/30/28 Due: 06/30/29

Breast Cancer Self-Efficacy Scale for Partners

Phase: N/A Priority: Normal
NCT ID: NCT05228210 Org: User:
Start: 09/01/19 End: 03/01/22 Due: 03/01/23

Medroxyprogesterone +/- Cyclophosphamide & Methotrexate in Hormone Receptor-Negative Recurrent/Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00577122 Org: User:
Start: 07/31/07 End: 12/31/11 Due: 12/31/12